Form 8-K · Current report
Moody's Corporation 8-K, filed Oct 21, 2026
- Filed
- CIK
- 0001059556
- Accession no.
- 0001628280-26-066594
Summary
Moody's Corporation reported third-quarter 2026 revenue of $2.0 billion, up 1% from a year earlier, and diluted EPS of $4.24, up 18%, while reaffirming its full-year 2026 guidance including diluted EPS of $16.00 to $16.50. CEO Rob Fauber cited strong profitability and cash generation in an increasingly complex operating environment.
Key points
- MCO revenue was $2.0 billion, up 1% year-over-year and 3% on an organic constant currency basis, with diluted EPS of $4.24, up 18%.
- Moody's Analytics revenue rose 3% (8% organic constant currency) to $936 million, with annualized recurring revenue up 8% to $3.7 billion.
- Moody's Investors Service revenue fell 1% to $1.1 billion, reflecting lower leveraged finance issuance against a record prior-year quarter.
- The board declared a quarterly dividend of $1.03 per share, payable December 11, 2026, to shareholders of record on November 20, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION 3 ITEM 7.01 REGULATION FD DISCLOSURE 3 ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS 3 SIGNATURES 4 EXHIBIT 99.1 2 Item 2.02, "Results of Operations and Financial Condition" On October 21, 2026, Moody's Corporation (the "Registrant") announced its financial results for the quarter ended September 30, 2026, as well as its outlook for 2026. A copy of the press release containing the announcement is included as Exhibit 99.1. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.